Kineticos, a life science strategy consulting company, announced on Thursday that it has named Frank Lis as its new president and chief executive officer of Kineticos Ventures, a new subsidiary of Kineticos Life Sciences.
Lis is also joining the Kineticos Ventures board. He has 30 years of experience as a senior executive in pharma and biotech. The company says that he has a vast knowledge of drug development, manufacturing, supply chain, quality systems and commercial operations. He has held the position of senior executive at various pharma services company. He also serves as a board member and advisor to a number of start-up biotechs. He was president of Sharp Clinical Services and vice president and general manager at Catalent Pharma Services.
In the new role with Kineticos, Lis will be responsible for Kineticos Ventures' long-term strategy and day to day execution.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer